Market capitalization is the total value the stock market puts on a company: its share price multiplied by the number of shares outstanding. Each point here is the share count reported in a filing multiplied by the closing price on that filing date, adjusted for later stock splits, so the history moves when a new filing arrives rather than with each day's trading. A larger market cap means investors collectively value the company more highly; by itself it says nothing about profit or debt. Annual points keep the latest observation in each calendar year.
Replimune Group, Inc. market cap for the quarter ending 2026-08-11 was $1.29B, a 189.49% increase year-over-year.
Replimune Group, Inc. market cap for the quarter ending 2026-06-30 was $928.81M, a 28.64% increase year-over-year.
Replimune Group, Inc. market cap for the quarter ending 2026-06-25 was $933.47M, a 29.28% increase year-over-year.
Replimune Group, Inc. market cap for the quarter ending 2026-03-31 was $632.78M, a 15.81% decline year-over-year.
Replimune Group, Inc. market cap for fiscal 2026 was $1.29B.
Replimune Group, Inc. market cap for fiscal 2025 was $774.01M, a 17.00% decline from fiscal 2024.
Replimune Group, Inc. market cap for fiscal 2024 was $932.58M, a 80.21% increase from fiscal 2023.
Replimune Group, Inc. market cap for fiscal 2023 was $517.5M, a 66.41% decline from fiscal 2022.